{"id":"NCT01177956","sponsor":"Merck KGaA, Darmstadt, Germany","briefTitle":"A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck","officialTitle":"Open-label, Single-arm, Multicenter, Phase III Trial to Assess the Antitumor Activity and Safety Profile of Cetuximab When Given in Combination With Chemotherapy for the First-line Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in Asian Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-12","primaryCompletion":"2011-01","completion":"2012-11","firstPosted":"2010-08-09","resultsPosted":"2012-08-10","lastUpdate":"2014-09-03"},"enrollment":73,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Squamous Cell Carcinoma of the Head and Neck"],"interventions":[{"type":"BIOLOGICAL","name":"Cetuximab","otherNames":["ErbituxÂ®"]},{"type":"DRUG","name":"Cisplatin","otherNames":[]},{"type":"DRUG","name":"5-Fluorouracil","otherNames":[]}],"arms":[{"label":"Cetuximab + Cisplatin + 5-Fluorouracil (5-FU)","type":"EXPERIMENTAL"}],"summary":"The primary objective of this trial is to assess the antitumor activity and safety profile of cetuximab when given in combination with cisplatin + 5-Fluorouracil (5-FU) for the first-line treatment of recurrent and/or metastatic Squamous Cell Carcinoma in Head and Neck (SCCHN) in Asian subjects.","primaryOutcome":{"measure":"Best Overall Response (BOR) Until Cut-off Date 25 January 2011","timeFrame":"Evaluations were performed every 6 weeks until progression, reported between day of first participant randomized, 25 December 2009, until cut-off date 25 January 2011","effectByArm":[{"arm":"Cetuximab + Cisplatin + 5-FU","deltaMin":54.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":21},"locations":{"siteCount":14,"countries":["China","South Korea"]},"refs":{"pmids":["24710768"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":68},"commonTop":["Leucopenia","Weight Decreased","Nausea","Rash","Hypomagnesaemia"]}}